<DOC>
	<DOCNO>NCT01002261</DOCNO>
	<brief_summary>The elimination carbohydrate galactose use daily clinical work liver patient quantitative measure metabolic liver function , liver test `` The Galactose Elimination Capacity '' , GEC . We work develop PET/CT scan procedure provide 3D image hepatic galactose elimination measurement regional value . This may use example plan resection stereotactic radiotherapy patient malignant tumor liver . Will patient able tolerate removal necessary part liver ? We include 10 patient liver cirrhosis 6 healthy human subject . Direct measurement hepatic galactose elimination ( successive constant iv infusion galactose increase dos measurement blood concentration galactose blood artery liver vein , measurement liver blood flow indocyanine green , Ficks principle ) compare PET/CT measurement iv injection 18F-labelled galactose analog , FDGal . Based previous study pig , perform detailed calculation hepatic galactose elimination kinetics two method , include estimation factor ( `` lump constant '' ) recalculate PET/CT data data natural galactose . Besides possible practical clinical importance , project elucidate basic problem concern liver metabolism use PET .</brief_summary>
	<brief_title>Hepatic Metabolism Galactose Galactose Analog FDGal Patients With Liver Disease Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Liver Extracts</mesh_term>
	<criteria>liver cirrhosis hepatic encephalopathy pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Galactose</keyword>
	<keyword>PET/CT</keyword>
	<keyword>Liver physiology</keyword>
	<keyword>Liver pathophysiology</keyword>
</DOC>